Jade Biosciences, Inc. (JBIO) Operating income 2020–2025
Jade Biosciences, Inc. (JBIO) annual operating income history from SEC filings — each fiscal year as reported.
-$113.5MFY2025 · since FY2020: -$8.9M → -$113.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$113.5M | -52.2% |
| FY2024 | -$74.6M | +8.4% |
| FY2023 | -$81.4M | -52.9% |
| FY2022 | -$53.2M | -131.2% |
| FY2021 | -$23.0M | -159.0% |
| FY2020 | -$8.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice